CNE100004447
CNE100004447
CATHAY BIOTECH INC
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 27.74B EUR | 34.51B EUR | 35.67B EUR |
Enterprise Value | 22.66B EUR | 25.92B EUR | 27.36B EUR |
Valuation Multiples | |||
Trailing P/E | 44.21x | 52.73x | 61.03x |
Forward P/E | 31.79x | -- | -- |
Price to Sales | 7.87x | 9.74x | 10.82x |
Price to Book | 1.54x | 1.94x | 2x |
EV/Revenue | 6.43x | 7.31x | 8.3x |
EV/EBITDA | 23.31x | 30.94x | 36.78x |
Price to FCF (P/FCF) | -- | 112.96x | -- |
EV/FCF | -- | 84.84x | -- |
FCF Yield | -1.96% | 0.89% | -1.13% |